FDA
Executive Summary
Office of Drug Evaluation I Assistant Director/Chemistry Charles Kumkumian, PhD, retires effective Jan. 3 after 31 years with the agency. Kumkumian, who has had oversight of the drug chemistry review process since 1972, plans to become a pharmaceutical consultant